6Mês·

Backgrounds Schott

$1SXP (+0,59%) Hi everyone, are you aware of the reasons why Schott is slumping - almost 25% in the last 3 months! Surely the figures are not that bad?

5 Comentários

Ludwig@tesla_diesel

6Mês

A weak start to the year, lowered analysts' expectations, the loss of a major customer, CFO Steinkühler leaving the company ... probably a mix of everything. The share price could therefore rise again once the uncertainty among analysts and investors subsides.

•

ZeissJessy@ZeissJessy

6Mês

Schott Pharma was and has not been a recommendation since listing: The company Schott Pharma

SCHOTT Pharma AG & Co. KGaA develops, produces and distributes solutions and delivery systems for injectable drugs for the pharmaceutical, biotechnology and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges and ampoules. Schott Pharma sold goods and services worth € 957.09 million in the past financial year. The company made a bottom-line profit of € 149.69 million.

•

Manny@Superrichy

6Mês

Which bulkhead do you mean?

••

Utilizador eliminado

6Mês

O comentário foi eliminado

Wolf_on_Waldstreet@W_o_W

6Mês

@Madhatter5566 @Superrichy sorry, I mean Schott Pharma DE000A3ENQ51 price target 29€

••